Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

about

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

Item

http://www.wikidata.org/entity/Q28219415

description

2006 nî lūn-bûn

@nan

2006 թուականին հրատարակուած գիտական յօդուած

@hyw

2006 թվականին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@ast

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@en

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@nl

type

Item

label

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@ast

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@en

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@nl

prefLabel

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@ast

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@en

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@nl

P1476

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

@en

P2093

Alexander G G Turpie

http://www.w3.org/2001/XMLSchema#string

P2860

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized

A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials

Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Perc

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.

P304

371-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17323591

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

Aat atak

P932

1994017

http://www.w3.org/2001/XMLSchema#string